Mehdi Shishehbor, DO, MPH

216.444.6697

Mehdi Shishehbor, DO, MPH

Appointed: 2009

Mehdi Shishehbor, DO, MPH
Department: Cardiovascular Medicine
Location: Cleveland Clinic Main Campus
Mail Code J3-5
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6697
DeskDesk:216.636.5918
WorkFax:216.445.6142
Surgeon:
No
Treats:
Adults Only

Biographical Sketch

Dr. Mehdi H. Shishehbor is the Director of Endovascular Services in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine. His area of expertise includes vascular medicine and minimally invasive, catheter-based procedures such as angioplasty, stent grafts, stenting, atherectomy and intravascular ultrasound to treat coronary, carotid, abdominal aortic aneurysms, and peripheral arterial and venous diseases. He is an expert on minimally invasive approaches to reconstruct lower extremity arteries in order to treat critical limb ischemia and prevent amputation. His work in this area has been recognized locally and nationally.

Dr. Shishehbor earned his undergraduate degree in chemistry at Florida International University, Miami followed by a Doctor of Osteopathy from Nova Southeastern University in Fort Lauderdale. He completed a Master’s degree in public health at Cleveland State University in 2004 and a doctorate in epidemiology at Case Western Reserve University in 2013.

Following completion of his DO degree, Dr. Shishehbor completed a one-year traditional internship at the Palmetto General Hospital in Hialeah, Fla. He became a resident in internal medicine in 2000 at Cleveland Clinic and was the first internal medicine resident to be granted the Crile Fellowship Award to support a year of basic research in the laboratory of Stanely Hazen, MD, PhD.

Dr. Shishehbor became a clinical fellow in cardiovascular medicine in 2004 and in interventional cardiology in 2007. After completing his interventional cardiology fellowship Dr. Shishehbor was awarded a sabbatical to train in carotid and aortic endovascular therapy under the mentorship of Bruce Gray, DO, of Greenville, SC, and Michael Bacharach, MD, with the North Central Heart Institute, Sioux Falls, SD. He joins the Cleveland Clinic medical staff upon completion of this fellowship.

Pursuing his interest in the epidemiology and treatment of cardiovascular disease, Dr. Shishehbor became the first Cleveland Clinic fellow to be awarded the National Institutes of Health KL-2 award. As a National Institutes of Health scholar, Dr. Shishehbor has a joint appointment at Case Western Reserve University and Cleveland Clinic. He is a respected researcher in cardiovascular medicine and has won a number of awards at international and national meetings, including being a research finalist at the American College of Cardiology and the American Heart Association Young Investigator Award competitions. In 2008 he was named the winner of the prestigious Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator award.

Dr. Shishehbor is widely published on cardiovascular epidemiology, interventional cardiology outcomes, and techniques in leading journals such as the Journal of American Medical Association, New England Journal of Medicine, Journal of the American College of Cardiology and Circulation. He also is the author of a number of textbook chapters, co-author of a book on coronary intensive care and a manuscript reviewer for several prestigious medical publications, including the Journal of the American Medical Association, Journal of the American College of Cardiology, American Journal of Cardiology, and Archives of Internal Medicine.

Dr. Shishehbor’s research interests include clinical outcomes in interventional cardiology, carotid and endovascular interventions. He has a special interest in novel minimally invasive percutaneous approaches to treat cardiac, venous, and arterial diseases.

He is board certified in internal medicine, cardiovascular medicine, and interventional cardiology. Dr. Shishehbor is highly involved in family life with his wife and his two children. He was born in Iran, and his wife is from Colombia. He speaks Persian (Farsi) and conversational Spanish. He enjoys cooking, soccer, and Persian poetry.

Education & Fellowships

Fellowship - Cleveland Clinic
Interventional Cardiology
Cleveland, OH USA
2009
Fellowship - Cleveland Clinic
Cardiovascular Disease
Cleveland, OH USA
2007
Graduate - Northeastern Ohio Universities College of Medicine
Rootstown, OH USA
2004
Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
2004
Research Fellowship - Cleveland Clinic
Crile
Cleveland, OH USA
2003
Internship - Palmetto General Hospital
Traditional Rotating Internship
Hialeah, FL USA
2000
Medical School - Nova Southeastern College of Osteopathic Medicine
Ft. Lauderdale, FL USA
1999
Undergraduate - Florida International University
Miami, FL USA
1995

Certifications

  • Internal Medicine
  • Internal Medicine- Cardiovascular Disease
  • Internal Medicine- Interventional Cardiology

Specialty Interests

Atherosclerosis, carotid artery disease, cerebrovascular disease, peripheral artery disease, angioplasty, coronary intervention, drug eluting stenting, iliac stenting, lower extremity angioplasty, renal angioplasty

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/30/2013, Dr. Shishehbor has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Persian
  • Spanish
  • Farsi
Cleveland Clinic Mobile Site